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B1b Lymphocytes Confer T Cell-Independent
Long-Lasting Immunity
provide crucial interactions necessary for the B cell re-
sponses (McHeyzer-Williams, 2003). This type of re-
sponse is referred to as a T cell-dependent (TD) antibody
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1Department of Molecular Genetics and Microbiology response. TD antigens are proteins such as tetanus,
diphtheria, and pertussis toxins and can be effectiveUniversity of Massachusetts Medical School
Worcester, Massachusetts 01655 vaccines that generate memory.
Unlike the TD antigens, the T cell-independent (TI)2 Department of Medical Chemistry
Graduate School of Medicine antigens do not typically generate B cell memory, and
the antibody responses therefore are short-lived (Lesin-Kyoto University
Kyoto 606-8501 ski and Westerink, 2001). TI antigens are classified as
type-1 (TI-1) and type-2 (TI-2). TI-1 antigens (e.g., lipo-Japan
polysaccharide [LPS]) can stimulate antigen-specific B
cells. In high concentration, TI-1 antigens will also stimu-
late nonspecific B cells. TI-2 antigens are multivalentSummary
polysaccharides or other antigens with repetitive struc-
tures that can extensively crosslink specific B cell anti-Many microbial pathogens employ antigenic variation
gen receptor (BCR) and thereby induce a specific anti-as a strategy to evade the immune system, posing a
body response (Vos et al., 2000). Clinically importantchallenge in vaccine development. To understand the
TI-2 antigens include those present in Haemophilus in-requirements for immunity against such pathogens,
fluenzae, Streptococcus pneumoniae, and Neisseriawe studied Borrelia hermsii, a relapsing fever bacte-
meningitidis, and these pathogens are leading causesrium. We found that mice deficient in T, follicular B,
of morbidity and mortality in children (Lesinski and West-marginal zone B, or B1a lymphocytes resolved B. hers-
erink, 2001). Although certain TI-2 antigens providemii bacteremia and became resistant to reinfection.
short-term protection in adults, they are not effectiveThe resolution of bacteremia coincided with an expan-
vaccines in children or the elderly, and the cellular andsion and persistence of B1b lymphocytes, and purified
molecular basis for this impairment in immunologicB1b lymphocytes from convalescent wild-type or TCR-
memory is not completely understood (Lesinski and
x/ mice conferred immunity to Rag1/ mice. The
Westerink, 2001).B1b lymphocytes in the reconstituted Rag1/ mice
Distinct subsets of B cells respond to TD and TI anti-provided long-lasting immunity by rapidly generating
gens. Mature B cells can be divided into follicular (FO),B. hermsii-specific IgM but not IgG upon bacterial
marginal zone (MZ), B1a, and B1b cell subsets and eachchallenge. Unmutated IgM is sufficient to eliminate
has a distinct function in the immune system (MartinB. hermsii, because AID/ mice deficient in somatic
and Kearney, 2001). FO B cells are the major subset inhypermutation and class switch recombination effi-
the body, recirculate among the B cell-rich lymphoidciently resolved all bacteremic episodes. These data
follicles, and participate in TD antigen responses. MZdemonstrate that B1b lymphocytes can provide long-
B cells, a minor subset, are localized to the marginallasting T cell-independent IgM memory.
sinus of the spleen. The FO B and MZ B subsets are
commonly referred to as B2 cells. B1 cells are most
Introduction abundant in coelomic cavities and can be subdivided
into B1a and B1b subsets (Stall et al., 1992). The B1a and
A hallmark of the adaptive immune system is immuno- MZ B cells participate in TI antigen responses (Martin et
logical memory, which generates long-lasting immunity al., 2001). Among the B cell subsets, a direct role for B1b
and is central to the concept of vaccination (MacLennan cells in immunity to infection has not been established.
et al., 2000). Conventional B cell memory is dependent A number of microbial pathogens employ antigenic
upon T cells and develops during the initial exposure to variation to evade the host immune system and pose a
antigens, during which a few antigen-specific B cells challenge for vaccine development. Relapsing fever is
proliferate and differentiate into short- and long-lived an infection caused by several species of Borreliae, in-
antibody-secreting plasma cells and long-lived memory cluding Borrelia hermsii (Burgdorfer, 1976). Relapsing
B cells. When the immune system is rechallenged with fever bacteria are predominantly localized in the blood,
the same antigen, memory B cells mount a very rapid causing recurring episodes of bacteremia. The periodic
antibody response, providing resistance to reinfection. recurrence in bacteremia is associated with alterations
A crucial event in the generation of B cell memory is the in the expression of surface antigens by DNA rearrange-
germinal center reaction, during which affinity matura- ments, resulting in escape from the host adaptive im-
tion of antibody by somatic hypermutation (SHM) of Ig mune system (Barbour, 1990).
variable regions and a change in Ig isotype by class Relapsing fever has been utilized as a model for in-
switch recombination (CSR) occur. T cells are essential vestigating the immune responses to pathogens that
for the formation of germinal center reactions, as they undergo antigenic variation. B cells and IgM, but not
T cells, are essential for the elimination of relapsing fever
Borreliae (Alugupalli et al., 2003a; Barbour and Bundoc,*Correspondence: kishore.alugupalli@umassmed.edu
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2001; Connolly and Benach, 2001; Newman and John- B1b cells were retained among the PerC cells of these
reconstituted Rag1/ mice after resolution of infectionson, 1984). We recently showed that FO B cells are
dispensable for the clearance of B. hermsii and that MZ (data not shown), and the mice were completely resis-
tant to reinfection when rechallenged 37 days later (Fig-B cells appear to play a role in protection only when
B. hermsii load is high (Alugupalli et al., 2003a). In con- ure 2C).
To address the possibility that other cells (i.e., IgM-trast, xid mice, which are severely deficient in both B1a
and B1b subsets, suffer particularly severe episodes of negative cells in Figure 1) in the MACS-enriched prepa-
ration were responsible for this protection, we furtherbacteremia (Alugupalli et al., 2003a). B1b cells expanded
concurrently with the resolution of bacteremia in wt mice purified the B1b cells from this preparation by FACS
using IgM and Mac1 (Figure 1). In contrast to unreconsti-and even more markedly in xid mice, suggesting that
B1b cells are involved in clearance of B. hermsii (Alugu- tuted Rag1/ mice, Rag1/ mice reconstituted with
2  105 FACS-purified B1b cells (IgMhigh Mac1) werepalli et al., 2003a).
In the present study, we utilized adoptive transfer to capable of clearing the first episode of bacteremia after
challenge with B. hermsii DAH-p1 a day after reconstitu-show that B1b cells from convalescent mice mount a
B. hermsii-specific antibody response and confer long- tion (compare Figures 2B and 2D, panel I). Although
these mice exhibited a low to moderate bacteremic re-lasting T cell-independent immunity. Unmutated IgM
was the sufficient component of this immune response, lapse 1–3 weeks after challenge (Figure 2D, panel I),
they remained subsequently bacteremia-free for an ad-as neither affinity maturation nor isotype switching of
Ig were required to eliminate B. hermsii. ditional 60 days (data not shown). In addition, reconstitu-
tion for longer periods before challenge improved the
protection of FACS-purified B1b cells. Mice reconstitu-
Results ted for 21 days exhibited a delay in the onset of bacter-
emia by 2–4 days, and one out of three mice experienced
Mice Deficient in T, FO B, MZ B, or B1a Cells Are only a single episode of bacteremia (Figure 2D, panel II
Resistant to B. hermsii Reinfection versus panel I). These mice were bacteremia-free when
Wild-type mice and mice deficient in T (TCR-x/), FO followed for 4 months and exhibited complete resis-
B (IL-7/), and MZ B (splenectomized) cells resolve tance to DAH-p1 rechallenge (data not shown). Finally,
B. hermsii DAH-p1 bacteremia, suggesting that B1 cells when Rag1/ mice were reconstituted with FACS-puri-
control B. hermsii infection (Alugupalli et al., 2003a). fied B1b cells for 60 days, only one of three mice exhib-
Consistent with such a possibility, xid mice that have ited detectable bacteremia upon B. hermsii challenge
very low numbers of B1a and B1b cells suffer more (Figure 2D, panel III). B1b cells were required for the
severe bacteremia than wt mice. However, the resolu- observed protection, because all the mice reconstituted
tion of bacteremia in xid mice coincided with a remark- for 21 days with the “B1b-depleted” preparation of cells
able expansion of B1b but not B1a cells (Alugupalli et al., (Figure 1) suffered multiple episodes followed by persis-
2003a). We hypothesized that B1b cells could generate tent bacteremia and became moribund (Figure 2E). The
protective responses to reinfection in convalescent initial control of bacteremia observed in this group of
mice. To test this, we challenged wt, TCR-x/, mice could be due to the presence of residual 4%
IL-7/, splenectomized, and xid mice with DAH-p1 60 B1b cells in the inoculum (see Figure 1). These results
or 230 days after the primary infection. Indeed, bacter- demonstrate that highly purified B1b cells from conva-
emia in these mice was undetectable, indicating that lescent mice can provide resistance to B. hermsii in-
the primary infection generated protective immunity and fection.
that T, FO B, MZ B, or B1a cells are not required for
this protection (Supplemental Table S1 at http://www.
immunity.com/cgi/content/full/21/3/379/DC1). Fur- Naive B1b Lymphocytes Offer Partial Control
thermore, these results suggest that B1b cells might of B. hermsii Bacteremia
confer long-term immunity. Rag1/ mice reconstituted with 2  105 of B1b cells
from convalescent mice experienced fewer episodes of
bacteremia following challenge with strain DAH-p1 thanB1b Lymphocytes of Convalescent Mice Confer
did naive mice (Figures 2A versus 2D), suggesting thatProtection against B. hermsii
B1b cells from naive mice have less protective activityTo directly determine whether B1b cells are capable
than those from convalescent mice. To test the extentof providing immunity, we transferred the B1b cells of
to which naive B1b cells protect against B. hermsii infec-convalescent mice into Rag1/ mice that are otherwise
tion, we reconstituted Rag1/ mice either with 2  105completely incapable of eliminating B. hermsii (Figure
FACS-purified naive B1b cells for 1 day or with MACS-2B; Alugupalli et al., 2003a). T, B1a, and B2 cells in the
enriched preparation containing 2 105 naive B1b cellsPerC cell preparation were depleted by MACS (2%
for 21 days and then challenged with either a high- (DAH-after depletion), thereby enriching B1b cells by5-fold,
p1) or moderate-virulence (DAH-p19) strain of B. hermsii.such that 27% of the remaining cells were B1b cells
The reconstituted mice suffered lower levels of bacter-(Figure 1). Rag1/ mice reconstituted with a MACS-
emia compared to unreconstituted Rag1/ mice, a dif-enriched PerC cell preparation containing 2  105 B1b
ference that was particularly apparent following infec-cells, when challenged with the virulent B. hermsii strain
tion with DAH-p19 (compare Figure 3A, panels II versusDAH-p1 1 day after reconstitution, resolved bacteremia
III, or Figure 3B, panel II). Nevertheless, the naive B1bafter 2 to 3 days and did not exhibit detectable relapses
at later time points (Figure 2C). Moreover, transferred cell-reconstituted Rag1/ suffered more severe infec-
B1b Lymphocytes Resolve B. hermsii Bacteremia
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Figure 1. Purification of B1b Lymphocytes
and Their Persistence in Rag1/ Recipients
Step 1: T and B1a cells (using anti-CD5) and
B2 cells (using anti-CD23) in the PerC cell
preparation of C57BL/6 naive or convales-
cent mice from B. hermsii strain DAH-p1 in-
fection (i.e., 2 months postinfected mice)
were depleted by MACS. After confirming the
depletion of T, B1a, and B2 cells by FACS
(plots not shown), the negatively selected
PerC cell preparation was stained with anti-
Mac1-PE and anti-IgM-FITC. Approximately
27% of this preparation contained B1b cells,
and at this stage, they are referred to as
“MACS-enriched B1b cells.”
Step 2: The B1b cells, in the MACS-enriched
B1b cell preparation, were purified by FACS
sorting (IgM and Mac-1 double-positive
cells); hence the term “FACS-purified B1b
cells.” After checking the purity (95%), 2 
105 B1b cells were transferred intraperitone-
ally into C57BL/6-Rag1/ mice. A total num-
ber of 8  105 B1b-depleted cells obtained
from the FACS were also transferred in paral-
lel to Rag1/ mice.
Step 3: The reconstitution of B1b cells in the
PerC of the recipient Rag1/ mice was con-
firmed 2 weeks or 3 months posttransfer. The
plots shown are after gating on IgM and
IgDlow cells (plots not shown), followed by the
identification of B1b cells using IgMhigh
Mac1. These cells were also confirmed to
be CD5 (plots not shown).
tion than did wt mice (compare Figure 3A, panels I versus express CD5, they resemble B1b cells with respect to
III, or Figure 3B, panel II) or Rag1/ reconstituted with other phenotypic characteristics, such as tissue distri-
B1b cells from convalescent mice (compare Figure 3B, bution and development (Stall et al., 1992) and are
panel II, versus Figure 2D, panel I). These results suggest known to mount immune responses to blood-borne TI
that naive B1b cells can partially control B. hermsii bac- antigens (Martin et al., 2001). To examine the possible
teremia. contribution of B1a cells to protection, we used BM
chimeras that efficiently reconstitute FO B, MZ B, and
B1b cells, but not B1a cells (Kantor et al., 1992). TheseB1a Cells Are Not Essential
B1a-deficient BM chimeras controlled B. hermsii DAH-for Clearing B. hermsii
p1 and p19 bacteremia as efficiently as the wt miceThe observation that Rag1/ reconstituted with naive
(Figure 3C, compare panels I and II), and supplementa-B1b cells suffered more severe bacteremia than did wt
tion of B1a cells to these BM chimeras, by the additionmice raised the possibility that other B cell subsets may
of PerC cells, did not accelerate the clearance of bacter-also contribute to the clearance of B. hermsii. We pre-
emia (Figure 3C, compare panels II and III). Finally, toviously showed that while MZ B cells might play a role
determine the extent to which naive B1a cells couldin resolving high-level bacteremia by DAH-p1, they are
provide protection, we transferred 2105 FACS-purifiednot essential for eliminating low-level bacteremia by
DAH-p19 (Alugupalli et al., 2003a). Although B1a cells B1a cells into Rag1/ mice and challenged these mice
Immunity
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Figure 2. B1b Lymphocytes from Convalescent Mice Confer Immunity
A naive wt mouse (A); unreconstituted Rag1/ mice (B); Rag1/ mice reconstituted with 2  105 MACS-enriched B1b cells (C; mice in this
panel were rechallenged with 5  104 DAH-p1, 37 days after the first challenge and indicated by arrow); Rag1/ mice reconstituted with 2 
105 FACS-purified B1b cells (D); or Rag1/ mice reconstituted with 8  105 B1b-depleted cells (E) were challenged with 5  104 DAH-p1
either 1 day or 21 or 60 days after reconstitution, and the bacteremia was measured by microscopic counting. Each plot represents bacteremia
in an individual mouse. The broken line in each plot indicates the detection limit for bacteremia. Mice that died during this bacteremia
monitoring period were indicated by an asterisk.
with DAH-p1 or -p19 1 day later. In contrast to naive B1 cell differentiation in vivo (Watanabe et al., 2000).
Likewise, the  T cells (Watanabe et al., 2000) couldB1b cells (Figure 3B, panel II), naive B1a cells did not
ontribute to the expansion of B1b cell numbers seenconfer any detectable protection, as bacteremia in these
in convalescent wt mice (Alugupalli et al., 2003a). Tomice was comparable to that of bacteremia in unrecon-
examine whether T cells play a role in the expansion ofstituted-Rag1/ mice (Figure 3B, panel III). These re-
B1b cells during B. hermsii infection or their function insults, as well as the previously documented lack of an
conferring immunity, we infected mice that completelyexpansion of B1a cells during B. hermsii infection (Alu-
lack mature T cells (TCR x/) with DAH-p1. We foundgupalli et al., 2003a), suggest that B1a cells do not play
a 2-fold increase in PerC B1b cell frequency (Figure 4A)a central role the resolution of B. hermsii infection.
and 3-fold increase in their absolute numbers (Figure
4B, Supplemental Table S1) in convalescent mice com-
T Cells Are Dispensable for Both the Expansion pared to naive mice. In contrast, the numbers of B1a
of B1b Cells and the Generation and B2 cells remained unaltered by infection (Figure
of Immunity by B1b Cells 4B). Consistent with this, when tested for the ability to
The  T cell subset can facilitate B1 cell migration from confer control of B. hermsii bacteremia upon reconstitu-
PerC to mesenteric lymph nodes, where they differenti- ted Rag1/ mice, the expanded B1b cells from conva-
lescent TCR x/ mice were indistinguishable fromate into antibody-secreting cells, and may also induce
B1b Lymphocytes Resolve B. hermsii Bacteremia
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Figure 3. Naive B1b but Not B1a Lympho-
cytes Provide Partial Control of B. hermsii
Bacteremia
(A) Naive wt mice (I); unreconstituted Rag1/
(II); or Rag1/ mice reconstituted for 21 days
with MACS-enriched B1b cells of naive wt
mice (III).
(B) Unreconstituted Rag1/ (I) and Rag1/
mice reconstituted for a day either with FACS-
purified naive B1b cells (II) or with FACS-puri-
fied naive B1a cells (III).
(C) Unirradiated wt (I); irradiated wt mice re-
constituted with wt BM (II) or irradiated wt
mice reconstituted with wt BM and PerC cells
(III). All the mice were infected with 5  104
DAH-p19 or DAH-p1 and the bacteremia was
measured. Mice that died during this bacter-
emia monitoring period were indicated by an
asterisk; § indicates 	5% of normal levels of
B1a cells; plus sign indicates reconstitution
of respective B cell subset to normal levels.
B1b cells from convalescent wt mice (compare Figures and IgG2b from convalescent mice were found to pro-
vide passive protection in a similar relapsing fever bac-4C and 4D and Figures 2C and 2D, panel I). These results
demonstrate that T cells are required neither for the B1b teremia model (Yokota et al., 1997). To examine whether
IgM is sufficient for the resolution of bacteremia, weexpansion nor for the resolution of B. hermsii bacteremia
(Alugupalli et al., 2003a) and suggest that B1b cells gen- infected AID/ mice, which are defective in CSR and
cannot generate isotypes other than IgM. Moreover,erate immunity independent of T cell help.
AID/mice are defective in SHM and are thus incapable
of generating mutated, affinity-matured antibodies. InIgM Is Sufficient and Affinity Maturation Is Not
Required for Resolving B. hermsii Infection spite of these defects, AID/ mice cleared the first bac-
teremic episode as rapidly as did the wt mice, and theIgM is a major immunoglobulin secreted by B1b cells,
and we previously showed that IgM was essential for duration and peak bacterial density of the relapses were
indistinguishable (Figure 5A). For both wt and AID/the resolution of B. hermsii bacteremia (Alugupalli et al.,
2003a). Nevertheless, it is possible that other isotypes mice, the induction of B. hermsii-specific IgM occurred
with identical kinetics and coincided with the clearanceplay a role in the clearance of B. hermsii, because IgG3
Immunity
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Figure 4. Expansion of B1b Lymphocytes
and the Immunity Conferred by Them Are T
Cell Independent
(A) PerC cells of naive or B. hermsii infection-
resolved (i.e., convalescent) TCR-x/mice
(40 dpi) were harvested and stained with anti-
bodies specific for IgM, IgD, and Mac1 or
CD5 and analyzed by flow cytometry. All B
cells were first identified by IgM and/or IgD
positivity (plots not shown) and were further
resolved as B1 (i.e., B1a plus B1b) or B1a
populations by Mac1 and CD5 positivity, re-
spectively. The frequency values of B1 and
B1a cells among all PerC cells were indicated
within the plots. The frequency of B1b cells
was inferred from the values obtained from
subtraction of the percent B1a (CD5) from
the percentage of all B1 cells (Mac1). The
data were generated by analyzing a minimum
of 20,000 cells and are representative of five
mice. 5% contour plots are shown.
(B) Selective expansion of B1b lymphocytes
but not B1a and B2 cells. PerC cells of naive
or convalescent TCR-x/ mice were har-
vested and stained with IgM, IgD, and Mac1
or CD5. The absolute cell counts of B2 (IgDhigh,
IgMlow, Mac1), B1a (IgMhigh, IgDlow, Mac1,
and CD5), and B1b (IgMhigh, IgDlow, Mac1,
and CD5) were determined as a product of
their frequency and the PerC cell yield. The
mean 
 SD values of five mice are shown.
Significant expansion of B1b cells occurred
in infected TCR-x/ mice (**p 	 0.002).
(C and D) Rag1/ mice reconstituted with
MACS-enriched B1b cells of convalescent
TCR-x/ mice (C); or Rag1/ mice recon-
stituted with FACS-purified B1b cells of con-
valescent TCR-x/ mice (D) were chal-
lenged with 5  104 DAH-p1 1 day after
reconstitution, and the bacteremia was mea-
sured by microscopic counting. Each plot
represents bacteremia in individual mouse
and three such mice in each group were
shown. The broken line in each plot indicates
the detection limit for bacteremia.
of bacteremia (Figure 5B). These results demonstrate demonstrate that the specific IgM required and suffi-
cient for the clearance of B. hermsii can be generatedthat unmutated IgM is sufficient and all other Ig isotypes
are dispensable for the elimination of each bacteremic by B1b cells.
episode of B. hermsii.
Persistent Expansion of B1b Lymphocytes
in B. hermsii-Infected MiceB1b Lymphocytes from Convalescent Mice Generate
B. hermsii-Specific IgM but Not IgG Given the previously shown expansion of the B1b cell
population during B. hermsii infection (Alugupalli et al.,Given that clearance of bacteremia in AID/ mice indi-
cated that IgM is sufficient for the resolution of B. herm- 2003a) and the long-lasting resistance to reinfection
(Supplemental Table S1), we examined the kinetics ofsii, we postulated that the transferred B1b cells in
Rag1/ mice confer protection by mounting a specific B1b cell expansion in B. hermsii-infected mice. We
chose xid mice to address this issue, since their basalIgM response against B. hermsii. To test this, we ana-
lyzed the specific IgM as well as IgG levels in Rag1/ level of B1b cells is much lower than that of wt mice
and any expansion form is easily measured. Indeed, amice reconstituted for 1 day with FACS-purified B1b
cells of convalescent wt mice. Indeed, these mice gener- detectable expansion of xid B1b cells is apparent by 7
days postinfection (Figure 6A), a time point coincidingated B. hermsii-specific IgM by 4–5 days after the infec-
tion, and the rise of this specific IgM response coincided with the resolution of the first bacteremic episode. As
shown previously, a dramatic expansion of B1b cellswith the resolution of bacteremia (Figure 5C). No
B. hermsii-specific IgG was detected. These results was apparent at 40 days postinfection (Alugupalli et al.,
B1b Lymphocytes Resolve B. hermsii Bacteremia
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Figure 5. Unmutated IgM Is Sufficient for Controlling B. hermsii Bacteremia
(A) The AID/ (wt; n  3) and AID/ (n  3) mice were infected with 5  104 DAH-p1, and the bacteremia was measured by microscopic
counting. The peak density and duration of the first as well as the second episodes of bacteremia were not statistically significant (by Student’s
t test), and each plot represents bacteremia in an individual mouse. The broken line indicates the detection limit for bacteremia.
(B) DAH-p1-specific IgM and IgG levels in blood were measured by ELISA using Ig standards (see Experimental Procedures).
(C) Rag1/ mouse reconstituted for 1 day with FACS-purified B1b cells of convalescent wt mice were infected, and bacteremia, B. hermsii-
specific IgM, and IgG were measured. The data from one representative mouse is shown.
2003a) and persisted for a remarkably long period, i.e., ever, when these mice were challenged with B. hermsii
DAH-p1 on the 60th day postreconstitution, specific IgMgreater than 230 days postinfection (Figure 6A). This
expansion was not detected in B2 or B1a cell subsets appeared as early as 48 hr after challenge (Figure 7,
Mouse #1) and reached maximal levels by 4 days. In(Figure 6B). These results indicate that long-term resis-
tance to reinfection correlates with a sustained B1b fact, detectable bacteremia occurred in only one of three
mice, and this episode was cleared concurrent with theexpansion.
appearance of IgM. These results indicate that long-
term immunity to B. hermsii was not due to long-livedGeneration of B. hermsii-Specific IgM
by the Expanded B1b Lymphocytes Is Not Constitutive plasma cells; rather, the expanded B1b cells persisted
for long time periods and generated specific IgM onlybut Is Induced upon Antigenic Stimulation
B cells specific for haptenated-LPS, a model TI-1 anti- upon antigenic stimulus.
gen, cease generating anti-hapten antibodies within
2 weeks after transfer into donor mice in the absence Discussion
of antigen restimulation (Colle et al., 1988). To determine
whether the B. hermsii-specific IgM is produced upon The ability to rapidly produce large amounts of neutraliz-
ing antibodies directed against blood-borne pathogensreconstitution or is antigen induced, we followed spe-
cific antibody levels in Rag1/ mice reconstituted with is often critical in the prevention of infection of vital
organs. TI antibody responses develop more quicklypurified B1b cells from convalescent wt mice. During
the 60 days following B1b cell transfer, B. hermsii-spe- than TD responses and therefore can play a crucial role
in decreasing the bacterial burden early in infectioncific IgM was undetectable by ELISA (Figure 7). How-
Immunity
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Figure 6. Persistent Expansion of B1b Lym-
phocytes in B. hermsii-Infected Mice
(A) PerC cells of uninfected or B. hermsii-
infected xid (CBA/N) mice at the indicated
days postinfection (dpi) were harvested, and
B1a  B1b (Mac1) and B1a (CD5) frequen-
cies were measured as in Figure 4 legend.
The data were generated by analyzing a mini-
mum of 20,000 cells and are representative
of 3 mice per time point. 5% contour plots
are shown.
(B) Selective expansion of B1b but not B1a
and B2 subsets. The absolute cell counts of
B2 (IgDhigh, IgMlow, Mac1), B1a (IgMhigh, IgDlow,
Mac1, and CD5), and B1b (IgMhigh, IgDlow,
Mac1, and CD5) were determined as in Fig-
ure 4 legend. The mean 
 SD values of re-
spective subsets of three mice at various dpi
are given. Significant expansion of B1b cells
occurred in infected xid mice (**p 	 0.002).
(Martin and Kearney, 2001). However, TI responses have ferred to Rag1/ mice, provide a level of protection,
albeit incomplete, against both high and moderate viru-not previously been thought to be capable of generating
long-term B cell memory. In the present study, we show lence B. hermsii.
We previously showed that clearance of B. hermsiithat TI responses generated by B. hermsii infection re-
sult in the expansion of a population of B1b cells that was accompanied by an expansion of B1b cells (Alugu-
palli et al., 2003a). In the current study, expansion wasis sufficient to conferring long-lasting immunity upon
otherwise immunodeficient mice. These B1b cells pro- apparent at the first time point tested, 7 days postinfec-
tion, just after clearance of the first episode of bacter-duce antigen-specific IgM, and immune mice produce
this antibody only after B. hermsii challenge, indicating emia. The cellular mechanisms behind this dramatic
expansion are not known. High concentrations (e.g.,that immunity is not mediated by long-lived plasma cells
(Slifka et al., 1998). Rather, antigenic stimulation is re- 1000 ng/ml) of IL-9 promote expansion of B1b cell num-
bers in vivo (Vink et al., 1999), but we found no evidencequired to promote differentiation of these lymphocytes
to plasma cells, suggesting that B1b cells produced by for a role for this cytokine in B1b cell expansion following
B. hermsii infection. First, the major cellular source ofa TI response are capable of functioning as long-lived
IgM memory B cells. IL-9 is the TH2 lymphocyte (Renauld et al., 1995), and
we found that the B1b cell expansion is T cell indepen-A TI IgM response is necessary for the control of
relapsing fever infection (Alugupalli et al., 2003a; Bar- dent. In addition, IL-9 levels in the serum of B. hermsii-
infected wt or T cell-deficient mice remained belowbour and Bundoc, 2001; Connolly and Benach, 2001;
Newman and Johnson, 1984), suggesting that MZ, B1a, detectable limits (i.e., 	0.3 ng/ml; K.R.A., unpublished
observation).and/or B1b cells may play a role in B. hermsii clearance
(Martin et al., 2001). MZ B cells have been shown to Remarkably, expansion of B1b cells occurred during
B. hermsii infection in xid mice (Figure 6; Alugupalli et al.,mount rapid responses to blood-borne TI antigens, but
splenectomized mice, which lack these cells, showed a 2003a), which are defective in BCR signaling, deficient in
B1 cells, and defective in generating TI-2 responsesdefect in B. hermsii clearance only during very high
bacterial loads (Alugupalli et al., 2003a, 2003b). Given (Berland and Wortis, 2002; Khan et al., 1995; Thomas et
al., 1993). xid mice can respond to TI-2 antigen-specificthat splenectomized mice also display a 4-fold defect
in the number of B1a cells (Wardemann et al., 2002), BCR-mediated activation when costimulatory signals
are provided (Couderc et al., 1987; Vinuesa et al., 2001),these results additionally suggest that this B cell subset
plays at most a subsidiary role in the control of relapsing suggesting that B. hermsii generates additional signals
to induce B cell activation and B1b expansion. Givenfever. Indeed, we showed here that B1a-deficient chime-
ric mice clear B. hermsii as efficiently as do normal mice that the expanded B1b cells generate antibody specific
for B. hermsii (see below), the expansion is likely to beand that B1a cells purified from naive mice are incapable
of conferring any degree of control of B. hermsii bacter- antigen driven. Neonatal B cells, like B cells from xid
mice, do not respond to TI-2 antigens (Chelvarajan etemia in otherwise immunodeficient (Rag1/) mice. In
contrast, B1b cells purified from naive mice, when trans- al., 1998), so identification of costimulatory pathways
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lished observation). It is possible that accessory cells
in the MACS-enriched B1b cell preparation synergized
with B1b cells to promote clearance. Indeed, bacteria-
primed peritoneal macrophages promote the differentia-
tion of B1a cells into plasmablasts (Balasz et al., 2002),
suggesting the possible involvement of primed acces-
sory cells of convalescent mice. Regardless of the differ-
ences in protective activity of MACS-enriched versus
FACS-purified B1b cells, the observation that B1b cells
from convalescent mice are more protective than those
from naive mice suggests that a subpopulation of
B. hermsii-stimulated B1b cells that are highly protective
undergo expansion during infection.
The protective activity produced by B1b cells is clearly
IgM. First, this isotype is one of the major isotypes pro-
duced by these cells, and mice defective for IgM produc-
tion or secretion are severely defective for control of
relapsing fever (Alugupalli et al., 2003a; Connolly and
Benach, 2001). Second, the appearance of spirochete-
specific IgM, but not IgG, coincided with clearance of
spirochetes (Figure 5; Connolly and Benach, 2001).
Third, antibodies that protect against relapsing fever
spirochetes are of the IgM isotype (Barbour and Bundoc,
2001; Connolly et al., 2004; Yokota et al., 1997). Finally,
AID/mice, which produce only IgM, were entirely com-
petent for clearance of B. hermsii.
While IgM produced by B1b cells is clearly an essential
effector, the nature of the antigen that is recognized by
this IgM has not yet been determined. Interestingly, the
ability of AID/ mice, which are incapable of SHM, to
Figure 7. Generation of B. hermsii-Specific IgM Response by B1b clear B. hermsii infection indistinguishably from wt mice
Lymphocytes Is Not Constitutive but Induced upon Antigen Stimu- demonstrates that unmutated IgM is sufficient to elimi-
lation nate B. hermsii. The present study is the first demonstra-
Rag1/ mice were reconstituted with FACS-purified B1b cells of tion that CSR and SHM can be dispensable for clearance
convalescent wt mice. B. hermsii-specific IgM was measured by of an active infection. Two monoclonal antibodies that
ELISA. On day 60 postreconstitution, mice were challenged with
have been shown to protect against relapsing fever spi-5 104 DAH-p1, indicated by arrow, and bacteremia was measured.
rochetes have both been directed against a variableEach plot represents data from individual mouse.
major protein (Vmp) (Barbour and Bundoc, 2001; Con-
nolly et al., 2004), the surface protein that determines
induced by B. hermsii could provide strategies to en- serotype and that undergoes high-frequency antigenic
hance immune responses to TI-2 antigens in children. variation (Barbour, 1990). These antibodies have been
The expansion of B1b cells during B. hermsii infection shown to be directly bactericidal, even in the absence
was associated not only with a greater number of these of complement (Barbour and Bundoc, 2001; Connolly
cells, but also with enhancement of their protective ac- et al., 2004). However, both of these antibodies were
tivity. B1b cells continued to expand over approximately produced by hybridomas generated from splenic B cells,
the first 40 days postinfection, and this progressive and whether the parental B cells were of the B1b sub-
expansion correlated with episodes of bacteremia of class is not known. It is curious that the repertoire of
diminishing severity. Indeed, maximal expansion corre- unmutated IgM would allow B1b cells to comprehen-
lated with the complete resolution of infection (Alugu- sively respond to hypervariable antigens such as Vmps.
palli et al., 2003a). More importantly, in contrast to a The pool of natural antibody, to which B1b cells contrib-
preparation of MACS-enriched B1b cells from naive ute, include antibodies directed against highly con-
mice, an analogous preparation of B1b cells from conva- served antigens (Casali and Schettino, 1996), and it is
lescent mice provided a high level of protection to possible that an element of protection may involve tar-
Rag1/ mice after only 1 day of reconstitution. FACS- geting of conserved, non-Vmp antigens on the surface
purified B1b cells from convalescent mice also provided of B. hermsii. An important future goal is to identify the
almost complete protection, although a longer period of target(s) of IgM produced by protective B1b cells.
reconstitution was required. The requirement for longer Remarkably, and unlike any previously characterized
reconstitution by FACS-purified compared to MACS- TI responses, the TI B1b cell response to B. hermsii
enriched B1b cells did not appear to be due to the infection confers long-lasting immunity. This TI re-
IgM and Mac1 labeling procedure used for the FACS sponse does not closely resemble a TI-2 response, be-
selection of B1b cells, since Rag1/ mice reconstituted cause not only have TI-2 antigens failed to elicit long-
for 1 day with a MACS-enriched B1b cell preparation lasting B cell memory (Lesinski and Westerink, 2001),
that had been labeled with anti-IgM and Mac1 still exhib- but in the current study, xid mice, which are deficient
in TI-2 responses (Thomas et al., 1993), were found toited only one episode of bacteremia (K.R.A., unpub-
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the bacteremia was monitored by dark-field microscopy (Alugupallibe resistant to reinfection (Supplemental Table S1). The
et al., 2001).model TI-1 antigen haptenated-LPS generates antigen-
specific B cells that persist for less than 2 weeks in
Flow Cytometryrecipient mice (Colle et al., 1988), whereas we showed
Peritoneal cavity (PerC) cells were harvested from individual mice
that B1b cells from convalescent mice survived and and the cell density was adjusted to 2.5 107/ml in staining medium
provided protective immunity to B. hermsii infection for (deficient RPMI medium 1640 [Irvine Scientific, Santa Ana, CA] with
3% new calf serum, 1 mM EDTA). After blocking the Fc receptorsmore than 80 days in recipient Rag1/ mice. Long-term
with 2.4G2 antibody (1 g per 106 cells), an aliquot of 25 l of PerCresponses to TI-1 antigens require continuous B cell
cells was incubated in a microtiter plate with appropriately dilutedrenewal from BM and perhaps antigen persistence as
antibody. The antibodies, anti-IgM-FITC (clone: 1B4B1), anti-IgD-well (Burlen et al., 1988; Colle et al., 1988; Zhang et
Biotin (clone: 11-26), anti-Mac1-PE (clone: M1/70), and anti-CD5 PE
al., 1988). In contrast, B1b cells generated by the TI (clone: 53-7.3) were purchased from eBioscience (San Diego, CA),
response to B. hermsii infection do not require B cell and streptavidin-PE-Cy5 was from PharMingen (San Diego, CA).
After staining, cells were washed twice with staining medium andinflux from the BM: 12-week-old IL-7/ mice, which
the preparations were run on a FACScalibur (Becton Dickinson,are arrested in B lymphopoiesis (Carvalho et al., 2001),
Mountain View, CA) using CELLQuest software for acquisition of theresolve B. hermsii bacteremia as efficiently as wt mice
data (Becton Dickinson). Data was analyzed using FlowJo software(Alugupalli et al., 2003a) and are resistant to reinfection
program (Treestar, San Carlos, CA).
(Supplemental Table S1). These B1b cells persist for
long periods (Figure 1) and mount antigen-specific IgM Irradiation Chimeras
response only upon antigen stimulation. Thus, the long- Irradiation chimeras were constructed using 2-month-old lethally
irradiated (1000 rads) C57BL/6J (Ly5.2) mice as recipients. A volumeterm immunity provided by B1b cells appears similar to
of 500 l (deficient RPMI medium 1640 [Irvine Scientific] with 1 mMthe immunity conferred by conventional memory B cells
EDTA) containing 3 106 bone marrow (BM) cells with or without(Schittek and Rajewsky, 1990) but is generated and
5  106 PerC cells from donor C57BL/6J (Ly5.1) mice were injectedmaintained in the complete absence of T cells. Elucida-
intravenously into the irradiated recipient mice via tail vein 1 day
tion of the pathways that result in B1b expansion and after irradiation. Chimeras were analyzed for reconstitution 2–3
the acquisition of long-lasting immunity in the absence months after cell transfers. As reported previously (Kantor et al.,
1992), BM cell transfer efficiently reconstituted FO, MZ, and B1bof T cells may provide approaches to enhance the effi-
cell subsets but not the B1a subset (B1a 	 5% of normal levels,cacy of TI responses in humans.
data not shown). The donor-derived B cell reconstitution was foundGeneration of unmutated IgM memory B cells specific
to be 90%–97% (Ly 5.1 positive).to the immunizing antigen can occur independent of
germinal center formation (Toyama et al., 2002). The
Reconstitution of Rag1/ Mice with B1b Lymphocytes
present study demonstrates that unmutated yet B. herm- We chose Rag1/ mice as recipients because these mice are inca-
sii-specific IgM can be generated during an infection pable of clearing B. hermsii (Alugupalli et al., 2003a) and lack not only
B cells but also T cells. A lack of competition by host lymphocytes inand are sufficient to resolve bacteremia. Ideal approach
Rag1/ mice facilitates efficient reconstitution of donor B1b cellsfor vaccine development against pathogens using anti-
without any requirement for a marker for chimerism or irradiationgenic variation requires the identification of protective
prior to donor cell transfer. Purification of B1b cells is outlined inand conserved epitopes. The sufficiency of unmutated
Figure 1. In brief, PerC cells (an anatomical compartment rich in
IgM for eliminating B. hermsii suggests that B1b cells B1b cells) were harvested from naive mice or mice convalescent
selected naturally during an infection may recognize from DAH-p1 infection (2 months postinfection). B2, B1a, and
T cells were depleted from the PerC cell preparation by magneticconserved epitopes and provide immunity. Therefore,
activated cell-sorting (MACS) (AutoMACS, Miltenyi Biotec, Auburn,screening for B1b cells with a BCR repertoire recogniz-
CA) using PE-conjugated anti-CD23 (to label B2 cells) and anti-CD5ing protective antigenic determinants will be of tremen-
(to label B1a and T cells) followed by anti-PE micro beads (Miltenyidous value in vaccine development against pathogens
Biotec). The depletion of B2 (97%), B1a (98%), and T (97%)
that undergo antigenic variation. cells was confirmed by flow cytometry (data not shown). Thus, the
lymphocyte population enriched in this negatively selected prepara-
tion is B1b cells, also referred as “MACS-enriched B1b cells” (FigureExperimental Procedures
1). The B1b cells from the MACS-enriched preparation were sorted
by FACSVantage SE (Becton Dickinson) using anti-IgM-FITC andMice and Infections
anti-Mac1-PE antibodies to 95% purity, and this preparation ofMice housed in micro-isolator cages with free access to food and
B1b cells is referred as “FACS-purified B1b cells” (Figure 1). A vol-water were maintained in a specific pathogen-free facility in the
ume of 500 l deficient RPMI 1640 with 1 mM EDTA containing 2 Department of Animal Medicine at the University of Massachusetts
105 B1b cells (comparable to the numbers of B1b cells in a naiveMedical School (UMMS). C57BL/6J, C57BL/6J-Rag1tm1 Mom (Rag1/),
murine peritoneal cavity) was injected i.p. into Rag1/ mice andand C57BL/6J-TCR-tm1 Mom TCR-tm1 Mom (TCR-x/) mice were pur-
the mice were infected 1, 21, or 60 days postreconstitution. A B1bchased from the Jackson Laboratories (Bar Harbor, ME). C57BL/6J
cell-depleted preparation obtained from a FACS sort containing 8mice splenectomized at the age of 4 weeks were also purchased
105 cells was also transferred into Rag1/ mice for reconstitution.from Jackson Laboratories and were infected with B. hermsii 2
The transferred B1b cells of naive or of convalescent mice main-or 6 weeks after splenectomy. IL-7/ mice on the 129SvC57BL/6
tained their numbers in the PerC of Rag1/ mice, when analyzedbackground were obtained from Dr. Richard Murray, DNAX Re-
2 (Figure 1) or 12 (data not shown) weeks postreconstitution, consis-search Institute, Palo Alto, CA (von Freeden-Jeffry et al., 1995). CBA/
tent with the self-replenishing characteristic of B1b cells (Kantor etCa and CBA/N (xid; X-linked immunodeficient) mice were purchased
al., 1995).from National Cancer Institute (Fredrick, MD). The AID/ mice on
C57BL/6 background (Muramatsu et al., 2000) were bred and main-
tained at UMMS. Reconstitution of Rag1/ Mice with Naive B1b
or B1a LymphocytesMice were infected intravenously via tail vein with 5 104 bacteria
of a fully virulent B. hermsii strain DAH-p1 (Schwan and Hinnebusch, IgM cells were isolated from the PerC cell preparation by MACS
(Miltenyi Biotec). The B1b cells (IgMhigh, Mac1, CD5) or B1a cells1998) or a partially attenuated strain DAH-p19, generated by serial
passage of DAH-p1 in vitro 18 times (Alugupalli et al., 2001), and (IgMhigh, Mac1, CD5) from the MACS-isolated IgM cells were
B1b Lymphocytes Resolve B. hermsii Bacteremia
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FACS sorted to 95% purity. A volume of 500 l deficient RPMI vated B cells in adult interleukin 7/mice. J. Exp. Med. 194, 1141–
1150.1640 with 1 mM EDTA containing 2  105 B1b or B1a cells were
injected i.p. into Rag1/ mice and the mice were infected 1 day Casali, P., and Schettino, E.W. (1996). Structure and function of
postreconstitution. natural antibodies. Curr. Top. Microbiol. Immunol. 210, 167–179.
Chelvarajan, R.L., Gilbert, N.L., and Bondada, S. (1998). Neonatal
Enzyme-Linked Immunosorbent Assay
murine B lymphocytes respond to polysaccharide antigens in the
IgM and IgG levels in blood were measured by enzyme-linked immu-
presence of IL-1 and IL-6. J. Immunol. 161, 3315–3324.
nosorbent assay (ELISA), according to manufacturer’s instructions
Colle, J.H., Truffa-Bachi, P., and Freitas, A.A. (1988). Secondary(Bethyl Laboratories, Montgomery, TX). The B. hermsii-specific IgM
response to thymus-independent antigens. Decline and life-span ofand IgG were determined by coating 96-well plates (ICN Biomedi-
memory. Eur. J. Immunol. 18, 1307–1314.cals, Aurora, OH) with in vivo grown B. hermsii DAH-p1 (105 wet
spirochetes), and the specific antibody levels were interpreted as Connolly, S.E., and Benach, J.L. (2001). The spirochetemia of murine
ng/l using IgM and IgG standards. relapsing fever is cleared by complement-independent bactericidal
To determine the IL-9 levels in the serum of B. hermsii-infected antibodies. J. Immunol. 167, 3029–3032.
mice (0, 2, 3, 4, or 6 day postinfected serum), ELISA was utilized in Connolly, S.E., Thanassi, D.G., and Benach, J.L. (2004). Generation
a sandwich format with rat anti-mouse IL-9 (clone: D8402E8) as a of a complement-independent bactericidal IgM against a relapsing
capturing mAb and biotinylated hamster anti-mouse IL-9 (clone: fever Borrelia. J. Immunol. 172, 1191–1197.
D9302C12) as detecting mAb. Recombinant mouse IL-9 was used
Couderc, J., Fevrier, M., Duquenne, C., Sourbier, P., and Liaco-as a positive control and standard. All the reagents for the IL-9
poulos, P. (1987). Xid mouse lymphocytes respond to TI-2 antigensdetection except streptavidin-horseradish peroxidase conjugate
when co-stimulated by TI-1 antigens or lymphokines. Immunology(Zymed Laboratories, San Francisco, CA) were purchased from Bec-
61, 71–76.ton Dickinson and the ELISA was performed according to manufac-
Kantor, A.B., Stall, A.M., Adams, S., Herzenberg, L.A., and Herzen-turer’s protocol.
berg, L.A. (1992). Differential development of progenitor activity for
three B-cell lineages. Proc. Natl. Acad. Sci. USA 89, 3320–3324.Acknowledgments
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